-
Capital, M&A & Industry Strategy20 hours agoOpentrons Raises $40M in Series E to Expand Its Robotics, Software, Data Infrastructure
According to the company, the funds will support the next phase of its growth in enabling autonomous science in labs and biopharmaceutical companies using its AI...
-
Manufacturing, Supply Chain & Infrastructure2 days agoBrain Quality Control Selectively Eliminates Neurons with Abnormal Variants in Development
In developing fetuses, the human brain generates an excess of neurons, most of which are eliminated around when the baby is born. New research suggests that...
-
AI, Machine Learning & Computational Biology1 week agoPerturbAI and OpenAI Launch AI Reasoning Agents for Biomedical Discovery
A year-long collaboration involving scientists at PerturbAI, OpenAI, and their other institutions yielded an AI reasoning framework that turns datasets into testable hypotheses, with thousands of...
-
Capital, M&A & Industry Strategy2 weeks agoTakara Bio USA, SPT Labtech Team Up to Automate NGS Library Prep Workflows
The partners are targeting NGS core labs with a combined offering that automates next-generation sequencing library prep workflows using kits from Takara Bio and SPT Labtech’s...
-
AI, Machine Learning & Computational Biology2 weeks agoDanaher, Nvidia Combine Lab Instrumentation and AI to Advance Autonomous Science
Danaher and Nvidia are collaborating to advance autonomous science, combining lab instrumentation, automation, and software with accelerated computing and AI so that experiments inform models and...
-
AI, Machine Learning & Computational Biology2 weeks agoNewly Identified Microexons Offer Clues to Autism Spectrum Disorder’s Genetic Roots
Hundreds of newly identified microexons seem to matter for autism and other neurological conditions, according to a Nature study. A machine learning model of their regulatory...
-
AI, Machine Learning & Computational Biology2 weeks agoIllumina Combines Multiomics Informatics Applications in New BioInsight Platform
Illumina is bringing its software, AI, and data offerings together in the new BioInsight platform, designed to help scientists analyze genomic and multiomic datasets. It will...
-
Drug Discovery & Therapeutics3 weeks agoEnodia Therapeutics Inks Pfizer Deal to Develop Sec61-Targeting Small Molecules
Backed by multiple Sec61 inhibitor families, proteomics and cryo-EM datasets, and machine learning-driven design, Enodia Therapeutics’ platform is the foundation of a new research collaboration and...
-
Global Biotechnology & Pharmaceutical Markets3 weeks agoImmune Cell Atlas Charts How People’s Aging Paths Diverge
Two people born on the same day can have immune systems that age differently. An immune cell atlas shows that a ratio between two cell types...
-
Manufacturing, Supply Chain & Infrastructure3 weeks agoARPA-H’s BoSS Program Funds Three Teams Tackling Cold Chain Challenges for Cell Therapies
Cell therapies and other biologics depend on ultracold storage and tightly controlled shipping. ARPA-H has funded teams of companies, research agencies, and universities developing alternatives, aiming...
FDA Grants Accelerated Approval to Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) for Recurrent Respiratory Papillomatosis
Opentrons Raises $40M in Series E to Expand Its Robotics, Software, Data Infrastructure
100 Million-Cell AI-Ready Dataset with Single-Cell and Proteomic Data Created by Parse and Nomic
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
